| Literature DB >> 31991777 |
Caroline Desclée de Maredsous1,2, Gabrielle Carlin1, Annemarie Oosting2, Corine Delteil1, Dalila Azzout-Marniche1, Catherine Chaumontet1, François Blachier1, Pierre Barbillon3, Tristan Mary-Huard3, Daniel Tomé1, Raish Oozeer2, Anne-Marie Davila1.
Abstract
Fetal and early postnatal nutritional environments contribute to lifelong health. High-protein (HP) intake in early life can increase obesity risk in response to specific feeding conditions after weaning. This study investigated the effects of a maternal HP diet during pregnancy and/or lactation on the metabolic health of offspring. Three groups of dams received a normal-protein (NP, 20E% proteins) diet during gestation and lactation (Control group), an HP diet (55E% proteins) during gestation (HPgest group), or an HP diet during lactation (HPlact group). From weaning until 10 weeks, female pups were exposed to the NP, the HP or the western (W) diet. HPgest pups had more adipocytes (p = 0.009), more subcutaneous adipose tissue (p = 0.04) and increased expression of genes involved in liver fatty acid synthesis at 10 weeks (p < 0.05). HPgest rats also showed higher food intake and adiposity under the W diet compared to the Control and HPlact rats (p ≤ 0.04). The post-weaning HP diet reduced weight (p < 0.0001), food intake (p < 0.0001), adiposity (p < 0.0001) and glucose tolerance (p < 0.0001) compared to the NP and W diets; this effect was enhanced in the HPgest group (p = 0.04). These results show that a maternal HP diet during gestation, but not lactation, leads to a higher susceptibility to obesity and glucose intolerance in female offspring.Entities:
Keywords: high-protein; obesity risk; perinatal
Year: 2020 PMID: 31991777 PMCID: PMC7071251 DOI: 10.3390/nu12020315
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Experimental design. d: day, HP: high-protein, NP: control, PND: post-natal day, W: western.
Figure 2Body weight of the female rat pups of the Control group (a), the HPlact group (b) and the HPgest group (c) from PND21 to PND68 and cumulated food intake of the female rat pups after weaning (d) Data are presented as means ± SEM (n = 8). Effects of diets, time and their interactions were tested within mixed Model 2. *** indicates that the group is significantly different from the others of the graph, ### means that the group is significantly different from the HPlact-NP group. ## Post-weaning HP diet groups are significantly different than the others. ** HPgest-W is significantly different of HPgest-NP.
Body adiposity and liver triglycerides at PND70, plasma lipids and glucose metabolism parameters of fasted female rat pups at PND68.
| Mother’s Diet | Control | HPlact | HPgest | Gestation Effect | Lactation Effect | Post-Weaning Effect | Interactions | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pup’s Diet | NP | HP | W | NP | HP | W | NP | HP | W | ||||
| Body adiposity | |||||||||||||
| Total adipose tissue, g | 28.2 ± 2.3 | 19.4 ± 1.3 | 30.2 ± 3.3 | 31.7 ± 3.8 | 17.6 ± 1.5 | 28.6 ± 2.6 | 31.5 ± 4.4 | 19.5 ± 1.3 | 42.5 ± 6.1 | 0.19 | 0.85 | <0.0001 | G × W 0.04 |
| Visceral adipose tissue, g | 21.3 ± 1.9 | 12.7 ± 1.0 | 22.7 ± 2.9 | 23.0 ± 2.9 | 11.8 ± 1.0 | 20.6 ± 2.0 | 20.5 ± 2.5 | 11.2 ± 0.8 | 30.0 ± 3.6 | 0.51 | 0.95 | <0.0001 | G × W 0.03 |
| Subcutaneous adipose tissue, g | 6.9 ± 0.7 | 6.7 ± 0.6 | 7.5 ± 0.7 | 8.6 ± 1.1 | 5.8 ± 0.7 | 7.9 ± 0.7 | 11.0 ± 2.1 | 8.3 ± 0.9 | 13.5 ± 2.8 | 0.04 | 0.76 | 0.005 | ø |
| Liver lipids | |||||||||||||
| Triglycerides, g/100 g of liver | 2.41 ± 0.20 | 2.13 ± 0.16 | 4.64 ± 0.83 | 1.88 ± 0.18 | 1.90 ± 0.12 | 3.73 ± 0.37 | 2.25 ± 0.24 | 1.96 ± 0.12 | 4.12 ± 0.44 | 0.44 | 0.14 | <0.0001 | ø |
| Plasma lipids | |||||||||||||
| Triglycerides, mmol/L | 0.80 ± 0.10 | 0.71 ± 0.07 | 1.02 ± 0.08 | 0.87 ± 0.14 | 0.59 ± 0.04 | 0.69 ± 0.05 | 0.92 ± 0.10 | 0.72 ± 0.12 | 1.11 ± 0.13 | 0.36 | 0.31 | 0.03 | ø |
| Total cholesterol, mmol/L | 2.22 ± 0.18 | 2.32 ± 0.13 | 2.16 ± 0.11 | 2.27 ± 0.09 | 2.49 ± 0.37 | 2.06 ± 0.10 | 2.32 ± 0.11 | 2.92 ± 0.45 | 2.14 ± 0.10 | 0.25 | 0.87 | 0.01 | ø |
| HDL cholesterol, mmol/L | 1.16 ± 0.09 | 1.28 ± 0.07 | 1.12 ± 0.05 | 1.19 ± 0.05 | 1.29 ± 0.15 | 1.09 ± 0.05 | 1.25 ± 0.06 | 1.57 ± 0.23 | 1.11 ± 0.07 | 0.21 | 0.98 | 0.007 | ø |
| Ratio HDL/total cholesterol | 0.52 ± 0.01 | 0.55 ± 0.01 | 0.52 ± 0.01 | 0.53 ± 0.01 | 0.53 ± 0.03 | 0.53 ± 0.02 | 0.54 ± 0.01 | 0.54 ± 0.03 | 0.52 ± 0.03 | 0.96 | 0.84 | 0.69 | ø |
| Nonesterified fatty acid, mmol/L | 1.21 ± 0.10 | 1.11 ± 0.16 | 1.62 ± 0.13 | 1.33 ± 0.11 | 1.13 ± 0.07 | 1.16 ± 0.13 | 1.07 ± 0.11 | 0.91 ± 0.14 | 1.18 ± 0.10 | 0.04 | 0.37 | 0.27 | ø |
| Glucose metabolism | |||||||||||||
| Fasted blood glucose, mg/dL | 83 ± 4 | 95 ± 4 | 77 ± 3 | 83 ± 4 | 90 ± 4 | 82 ± 4 | 77 ± 3 | 105 ± 5 | 83 ± 2 | 0.30 | 0.95 | <0.0001 | G × W 0.02 |
| Fasted plasma insulin, µg/L | 0.18 ± 0.02 | 0.21 ± 0.02 | 0.18 ± 0.03 | 0.24 ± 0.05 | 0.14 ± 0.03 | 0.22 ± 0.02 | 0.23 ± 0.04 | 0.28 ± 0.06 | 0.21 ± 0.04 | 0.25 | 0.90 | 0.74 | ø |
| HOMA-IR | 0.81 ± 0.12 | 1.12 ± 0.15 | 0.76 ± 0.16 | 0.12 ± 0.30 | 0.71 ± 0.15 | 0.98 ± 0.14 | 0.98 ± 0.21 | 1.58 ± 0.35 | 0.94 ± 0.21 | 0.21 | 0.90 | 0.64 | ø |
| Fasted plasma glucagon, pg/mL | 30.9 ± 3.0 | 35.5 ± 4.4 | 28.0 ± 3.0 | 24.2 ± 4.5 | 25.5 ± 2.9 | 24.9 ± 3.0 | 50.9 ± 10.3 | 42.8 ± 8.9 | 44.9 ± 9.6 | 0.02 | 0.29 | 0.81 | ø |
Values are presented as means ± SEM, (n = 8). Effects of diets and interactions were tested within mixed model 1. G × W: gestation × post-weaning, NEFA: non esterified fatty acids, PND: post-natal day.
Figure 3Adipocytes in peri-ovarian adipose tissue of female rat pups at PND70. Number of adipocytes in total peri-ovarian adipose tissue (a) and peri-ovarian adipocyte size of pups receiving the post-weaning NP diet (b), W diet (c) and HP diet (d). Data are represented as means ± SEM with individual values for (a), (n = 8). Effects of diets, time and their interactions were tested within mixed Model 1.
Figure 4Blood glucose during an oral glucose tolerance test on female rat pups at PND68. Data are represented as means ± SEM, (n = 8). Effects of diets, time and their interactions were tested within mixed Model 2. * post-weaning HP diet groups significantly different than the others.
Changes in mRNA encoding for genes in liver of fed female rat pups at PND70.
| Mother’s Diet | Control | HPlact | HPgest | Gestation Effect | Lactation Effect | Post Weaning Effect | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pup’s Diet | NP | HP | W | NP | HP | W | NP | HP | W | |||
| Liver mRNA Encoding for | ||||||||||||
| FAS | 1.00 ± 0.20 | 0.57 ± 0.16 | 0.37 ± 0.09 | 1.19 ± 0.24 | 0.40 ± 0.06 | 0.28 ± 0.06 | 1.93 ± 0.35 | 1.21 ± 0.25 | 0.85 ± 0.23 | 0.002 | 0.93 | <0.0001 |
| ACC | 1.00 ± 0.16 | 0.50 ± 0.12 | 0.44 ± 0.06 | 0.96 ± 0.21 | 0.46 ± 0.10 | 0.31 ± 0.05 | 1.43 ± 0.19 | 0.94 ± 0.23 | 0.81 ± 0.20 | 0.006 | 0.58 | <0.0001 |
| Scd1 | 1.00 ± 0.31 | 0.50 ± 0.14 | 0.17 ± 0.03 | 1.09 ± 0.32 | 0.42 ± 0.11 | 0.13 ± 0.03 | 1.64 ± 0.21 | 1.08 ± 0.31 | 0.64 ± 0.16 | 0.006 | 0.95 | 0.0001 |
| MTTP | 1.00 ± 0.08 | 0.95 ± 0.13 | 1.14 ± 0.22 | 0.99 ± 0.14 | 0.71 ± 0.11 | 0.89 ± 0.08 | 1.14 ± 0.11 | 1.20 ± 0.22 | 1.08 ± 0.14 | 0.51 | 0.31 | 0.77 |
| GPAT | 1.00 ± 0.16 | 0.78 ± 0.14 | 0.59 ± 0.10 | 0.97 ± 0.18 | 0.47 ± 0.07 | 0.50 ± 0.06 | 1.20 ± 0.17 | 0.95 ± 0.18 | 0.82 ± 0.13 | 0.11 | 0.26 | 0.007 |
| DGAT | 1.00 ± 0.11 | 1.18 ± 0.18 | 1.09 ± 0.24 | 0.99 ± 0.14 | 0.75 ± 0.14 | 0.79 ± 0.07 | 1.06 ± 0.09 | 1.50 ± 0.27 | 1.04 ± 0.13 | 0.55 | 0.15 | 0.41 |
| CPT1 | 1.00 ± 0.28 | 1.08 ± 0.58 | 1.32 ± 0.46 | 0.42 ± 0.08 | 0.26 ± 0.03 | 0.76 ± 0.10 | 0.71 ± 0.13 | 1.23 ± 0.53 | 1.44 ± 0.21 | 0.86 | 0.12 | 0.17 |
| ACOX1 | 1.00 ± 0.14 | 1.12 ± 0.17 | 1.03 ± 0.21 | 0.95 ± 0.13 | 0.74 ± 0.18 | 0.91 ± 0.10 | 0.99 ± 0.09 | 1.64 ± 0.36 | 1.23 ± 0.14 | 0.22 | 0.35 | 0.39 |
| LPK | 1.00 ± 0.12 | 0.44 ± 0.10 | 0.64 ± 0.14 | 0.86 ± 0.12 | 0.30 ± 0.06 | 0.44 ± 0.08 | 1.22 ± 0.15 | 0.74 ± 0.17 | 0.76 ± 0.11 | 0.049 | 0.13 | <0.0001 |
| GK | 1.00 ± 0.20 | 0.42 ± 0.08 | 1.05 ± 0.23 | 1.26 ± 0.34 | 0.33 ± 0.06 | 0.62 ± 0.15 | 1.17 ± 0.32 | 0.58 ± 0.16 | 1.05 ± 0.27 | 0.56 | 0.64 | 0.001 |
| PEPCK | 1.00 ± 0.35 | 1.53 ± 0.30 | 1.18 ± 0.71 | 0.29 ± 0.11 | 0.87 ± 0.33 | 0.74 ± 0.13 | 0.52 ± 0.20 | 2.23 ± 0.66 | 1.02 ± 0.23 | 0.93 | 0.19 | 0.007 |
| G6PC1 | 1.00 ± 0.17 | 0.42 ± 0.14 | 0.93 ± 0.37 | 0.50 ± 0.09 | 0.36 ± 0.07 | 0.55 ± 0.09 | 0.75 ± 0.17 | 1.20 ± 0.46 | 0.95 ± 0.17 | 0.55 | 0.26 | 0.72 |
Values are presented as means ± SEM, (n = 8). Effects of diets and interactions were tested within mixed Model 1. Ribosomal 18S RNA was used as the internal control. Results are expressed as ratio of expression with Control-NP group. ACC: acetyl-CoA carboxylase, Acox1: acyl-CoA oxidase 1, CPT1: Carnitine palmitoyltransferase I, DGAT: diglyceride acyltransferase, FAS: fatty acid synthase, GK: glucokinase, GPAT: glycerol-3-phosphate acyltransferase, G6PC1: Glucose-6-phosphatase, LPK: L-pyruvate kinase, LPL: lipoprotein lipase, MTTP: microsomal triglyceride transfer protein, PND: post-natal day, PEPCK: Phosphonolpyruvate carboxykinase, Scd1: stearoyl-CoA desaturase 1.